Crucell: Investors

Home | Contact | Search | Site Map

About Us

	Corporate Profile
	Share Information
	Financial Information
	Press Releases
	Presentations
	Shareholder Services
	Event Calendar
	Investor Relations Contact
	Crucell's press releases are available via an RSS feed. To add this RSS feed to your reader, right click on the RSS button, click "Copy Shortcut" and add the URL to your feed reader. If you are new to RSS, we suggest you read the Introduction to RSS article.

2009 \| 2008 \| 2007 \| 2006 \| 2005 \| 2004 \| 2003 \| 2002 \| 2001 \| 2000

16 Nov 2009	Crucell launches global brand to reflect and reinforce its leading position in healthcare innovation
03 Nov 2009	Crucell Announces Third Quarter 2009 Results
21 Oct 2009	Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris
20 Oct 2009	Crucell Rabies Monoclonal Antibody Combination: Positive Results Philippines Phase II Study Presented at RITA Conference
30 Sep 2009	Crucell Strengthens its Vaccine Sales in the UK with a Dedicated Marketing and Sales Organization
28 Sep 2009	Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment
18 Aug 2009	Crucell Receives NIH Award for the Development of Influenza Monoclonal Antibodies
17 Aug 2009	New awards of $300 million for Quinvaxem® bringing total value up to $800 million
11 Aug 2009	Crucell Announces Second Quarter 2009 Results
04 Aug 2009	Crucell to Release Q2 2009 Results on Tuesday August 11, 2009
29 Jul 2009	MVI and Crucell Announce Collaboration new Malaria Vaccine Approach
24 Jun 2009	Crucell Announces Positive Results of Phase II Clinical Study Rabies Monoclonal Antibody Combination in Philippines
05 Jun 2009	Crucell 2009 Annual General Meeting of Shareholders 2008 Financial Statements Adopted; All Resolutions Approved
06 May 2009	Crucell Announces First Quarter 2009 Results
29 Apr 2009	Crucell to Release First Quarter 2009 Results on Wednesday, May 6, 2009
28 Apr 2009	Aeras and Crucell Announce Start of TB Infant Study in South Africa
24 Apr 2009	Crucell Announces Release 2008 Annual Report and Form 20-F
26 Feb 2009	Crucell's Revolutionary Antibody for Universal Therapy Against Flu
10 Feb 2009	DSM and Crucell Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6® Cell Line Proteins
05 Feb 2009	Crucell Announces Profits for Full Year 2008
04 Feb 2009	Crucell to Release Q4 & FY 2008 Results on Thursday, February 5, 2009
26 Jan 2009	Discussions on a Combination of Crucell and Wyeth Discontinued
07 Jan 2009	Crucell and Wyeth in discussion on a combination of the two companies
06 Jan 2009	Crucell Announces STAR® Research and Commercial License Agreement with Centocor, Inc.